These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22168311)

  • 21. Gonococcal antimicrobial resistance: challenges for public health control.
    Ndowa FJ; Ison CA; Cole MJ; Lusti-Narasimhan M
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv3-4. PubMed ID: 24243877
    [No Abstract]   [Full Text] [Related]  

  • 22. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan.
    Ohnishi M; Saika T; Hoshina S; Iwasaku K; Nakayama S; Watanabe H; Kitawaki J
    Emerg Infect Dis; 2011 Jan; 17(1):148-9. PubMed ID: 21192886
    [No Abstract]   [Full Text] [Related]  

  • 23. Resistance trends in Neisseria gonorrhoeae in southwestern Ohio.
    Herchline TE; Inkrott BP
    Sex Transm Dis; 2010 Feb; 37(2):121-2. PubMed ID: 19901861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonococcal antimicrobial resistance: the implications for public health control.
    Ndowa FJ; Ison CA; Lusti-Narasimhan M
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv1-2. PubMed ID: 24243872
    [No Abstract]   [Full Text] [Related]  

  • 25. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains.
    Bala M; Ray K; Gupta SM; Muralidhar S; Jain RK
    J Antimicrob Chemother; 2007 Sep; 60(3):582-6. PubMed ID: 17604320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997 2006.
    Tapsall JW; Limnios EA; Murphy D;
    J Antimicrob Chemother; 2008 Jan; 61(1):150-5. PubMed ID: 17986492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delaying the widespread emergence of cephalosporin-resistant gonorrhoea: what is the best target?
    Tuddenham S; Ghanem KG
    Sex Transm Infect; 2015 Jun; 91(4):232-3. PubMed ID: 25990778
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug-resistant Neisseria gonorrhoeae: latest developments.
    Suay-García B; Pérez-Gracia MT
    Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1065-1071. PubMed ID: 28210887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cephalosporin-resistant gonorrhea: it's just a matter of time.
    Deresinski S
    AIDS Alert; 2011 Oct; 26(10):115-6. PubMed ID: 22096785
    [No Abstract]   [Full Text] [Related]  

  • 30. Characterization of profile of multidrug-resistant Neisseria gonorrhoeae using old and new definitions in India over a decade: 2000-2009.
    Bala M
    Sex Transm Dis; 2011 Nov; 38(11):1056-8. PubMed ID: 21992984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae.
    Matsumoto T
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S35-9. PubMed ID: 18164598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low prevalence of ciprofloxacin-resistant Neisseria gonorrhoeae in Nuuk, Greenland.
    Pedersen ML; Clausen-Dichow P; Poulsen P; Nyborg H; Jensen JS
    Sex Transm Dis; 2013 Aug; 40(8):639-40. PubMed ID: 23859910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae.
    Cole MJ; Chisholm SA; Hoffmann S; Stary A; Lowndes CM; Ison CA;
    Sex Transm Infect; 2010 Nov; 86(6):427-32. PubMed ID: 20940154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First cases of Neisseria gonorrhoeae resistant to ceftriaxone in Catalonia, Spain, May 2011.
    Carnicer-Pont D; Smithson A; Fina-Homar E; Bastida MT;
    Enferm Infecc Microbiol Clin; 2012 Apr; 30(4):218-9. PubMed ID: 22244992
    [No Abstract]   [Full Text] [Related]  

  • 35. Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden.
    Golparian D; Hellmark B; Fredlund H; Unemo M
    Sex Transm Infect; 2010 Nov; 86(6):454-60. PubMed ID: 20940159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing figures of antimicrobial susceptibility and serovar distribution in Neisseria gonorrhoeae isolated in Greece.
    Tzelepi E; Avgerinou H; Flemetakis A; Siatravani E; Stathi M; Daniilidou M; Miriagou V
    Sex Transm Dis; 2010 Feb; 37(2):115-20. PubMed ID: 19901866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of the variability of gonococci in the development of therapeutic-prophylactic measures in gonorrhea].
    Mavrov II; Gorisiuk AF
    Mikrobiol Zh (1978); 1987; 49(4):62-4. PubMed ID: 3150499
    [No Abstract]   [Full Text] [Related]  

  • 38. Emergence of quinolone-resistant Neisseria gonorrhoeae in Pakistan.
    Jabeen K; Khan E; Hasan R
    Int J STD AIDS; 2006 Jan; 17(1):30-3. PubMed ID: 16409676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
    Chisholm SA; Alexander S; Desouza-Thomas L; Maclure-Webster E; Anderson J; Nichols T; Lowndes CM; Ison CA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2509-12. PubMed ID: 21846672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sharp increase in ciprofloxacin resistance of
    Crucitti T; Belinga S; Fonkoua MC; Abanda M; Mbanzouen W; Sokeng E; Nzouankeu A
    Int J STD AIDS; 2020 May; 31(6):579-586. PubMed ID: 32316853
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.